IDH2 and intrahepatic cholangiocarcinoma: The incidence of IDH1/2 mutations in ICC is approximately 25%, and the sites with higher mutation frequency are IDH1 R132C/H/L/S, IDH2 R140Q and IDH2 R172K/W [9,10].